首页 > 最新文献

Pituitary最新文献

英文 中文
Oral and gut microbiota after acromegaly treatment: prospective assessment and insights from machine learning. 肢端肥大症治疗后的口腔和肠道微生物群:前瞻性评估和机器学习的见解。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-29 DOI: 10.1007/s11102-025-01624-y
Aysa Hacioglu, Zuleyha Karaca, Emre Urhan, Ahmet Numan Demir, Serdar Sahin, Aycan Gundogdu, Mehmet Hora, Ozkan Ufuk Nalbantoglu, Sukru Oral, Necmettin Tanriover, İzzet Ökçesiz, Hatice Sebile Dokmetas, Pinar Kadıoglu, Kursad Unluhizarci, Fahrettin Kelestimur

Purpose: The human endocrine system and microbiota interact bidirectionally. Patients with acromegaly have distinct oral and gut microbiota profiles. The study aims to investigate the effects of acromegaly treatment on oral and fecal microbiota and evaluate their associations with insulin-like growth factor-1 (IGF-1) normalization. The predictive value of baseline microbiota-based machine learning algorithms regarding treatment outcomes is also analyzed.

Methods: Oral and fecal microbiota samples were prospectively collected from newly diagnosed acromegaly patients before and one year post-treatment. Following DNA isolation 16 S rRNA sequencing was performed, and bioinformatic analyses were conducted.

Results: A total of 19 patients were included (10 female(52.6%); mean age 48.8 ± 12.1 years). Seven patients achieved remission with surgery alone (Group 1), seven with combined surgical and medical treatment (Group 2), while five did not achieve remission (Group 3). Alpha and beta diversities were similar but microbial compositions differed significantly among the groups. In prospective analyses of Group 1 and combined Groups 1 and 2, microbiota profiles changed significantly. In Group 1, decrease in IGF-1 levels correlated positively with oral Succinivibrio. The developed classification model, using baseline microbiota profiles, accurately distinguished between the groups, and identified patients who achieved complete remission after surgery alone.

Conclusion: Oral and fecal microbiota compositions in patients with acromegaly significantly change with treatment modalities and remission status with some taxa correlating with IGF-1 normalization. The findings provide preliminary evidence that microbiota may help predict treatment response. Further studies with larger patient populations are needed to validate the results.

目的:人体内分泌系统与微生物群相互作用。肢端肥大症患者具有不同的口腔和肠道菌群特征。本研究旨在探讨肢端肥大症治疗对口腔和粪便微生物群的影响,并评估它们与胰岛素样生长因子-1 (IGF-1)正常化的关系。还分析了基于微生物群的基线机器学习算法对治疗结果的预测价值。方法:前瞻性收集新诊断肢端肥大症患者治疗前和治疗后1年的口腔和粪便微生物群样本。DNA分离后进行16s rRNA测序,并进行生物信息学分析。结果:共纳入19例患者,其中女性10例(52.6%);平均年龄48.8±12.1岁)。7例患者通过单纯手术获得缓解(第1组),7例采用手术和药物联合治疗(第2组),5例未获得缓解(第3组)。α和β多样性相似,但微生物组成差异显著。在前瞻性分析中,第1组和第1、2联合组的微生物群谱发生了显著变化。在第1组中,IGF-1水平的下降与口服琥珀酸弧菌呈正相关。开发的分类模型,使用基线微生物群概况,准确区分各组,并确定仅在手术后实现完全缓解的患者。结论:肢端肥大症患者的口腔和粪便微生物群组成随着治疗方式和缓解状态的改变而发生显著变化,其中一些微生物群与IGF-1正常化相关。这些发现为微生物群可能有助于预测治疗反应提供了初步证据。需要在更大的患者群体中进行进一步的研究来验证结果。
{"title":"Oral and gut microbiota after acromegaly treatment: prospective assessment and insights from machine learning.","authors":"Aysa Hacioglu, Zuleyha Karaca, Emre Urhan, Ahmet Numan Demir, Serdar Sahin, Aycan Gundogdu, Mehmet Hora, Ozkan Ufuk Nalbantoglu, Sukru Oral, Necmettin Tanriover, İzzet Ökçesiz, Hatice Sebile Dokmetas, Pinar Kadıoglu, Kursad Unluhizarci, Fahrettin Kelestimur","doi":"10.1007/s11102-025-01624-y","DOIUrl":"10.1007/s11102-025-01624-y","url":null,"abstract":"<p><strong>Purpose: </strong>The human endocrine system and microbiota interact bidirectionally. Patients with acromegaly have distinct oral and gut microbiota profiles. The study aims to investigate the effects of acromegaly treatment on oral and fecal microbiota and evaluate their associations with insulin-like growth factor-1 (IGF-1) normalization. The predictive value of baseline microbiota-based machine learning algorithms regarding treatment outcomes is also analyzed.</p><p><strong>Methods: </strong>Oral and fecal microbiota samples were prospectively collected from newly diagnosed acromegaly patients before and one year post-treatment. Following DNA isolation 16 S rRNA sequencing was performed, and bioinformatic analyses were conducted.</p><p><strong>Results: </strong>A total of 19 patients were included (10 female(52.6%); mean age 48.8 ± 12.1 years). Seven patients achieved remission with surgery alone (Group 1), seven with combined surgical and medical treatment (Group 2), while five did not achieve remission (Group 3). Alpha and beta diversities were similar but microbial compositions differed significantly among the groups. In prospective analyses of Group 1 and combined Groups 1 and 2, microbiota profiles changed significantly. In Group 1, decrease in IGF-1 levels correlated positively with oral Succinivibrio. The developed classification model, using baseline microbiota profiles, accurately distinguished between the groups, and identified patients who achieved complete remission after surgery alone.</p><p><strong>Conclusion: </strong>Oral and fecal microbiota compositions in patients with acromegaly significantly change with treatment modalities and remission status with some taxa correlating with IGF-1 normalization. The findings provide preliminary evidence that microbiota may help predict treatment response. Further studies with larger patient populations are needed to validate the results.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"25"},"PeriodicalIF":3.4,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates. 肢端肥大症患者的心理特征:人格特征、生活质量和临床相关性。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-26 DOI: 10.1007/s11102-025-01622-0
Banu Betul Kocaman, Yusuf Cicek, Serdar Sahin, Ahmet Burhan Dogan, Serhat Uysal, Ilkin Muradov, Lala Soltanova, Sabriye Sibel Taze, Nazife Gamze Usta Saglam, Emre Durcan, Senol Turan, Pinar Kadioglu

Objective: This study evaluated temperament, character dimensions, anxiety, depression, and quality of life (qol) in patients with acromegaly, and examined their associations with clinical variables including disease activity, duration, treatment modality, and tumor characteristics.

Methods: In a cross-sectional study, 77 patients with acromegaly and 99 healthy controls with no difference in age and sex compared to patients completed the Temperament and Character Inventory-Revised (TCI-R), Hospital Anxiety and Depression Scale (HADS), and Acromegaly Quality of Life Questionnaire (AcroQoL). Patients were subgrouped by remission status, treatment type, and histopathological findings. Between-group comparisons and correlation analyses were performed.

Results: Compared with controls, patients with acromegaly exhibited higher impulsiveness but lower levels of emotional warmth, persistence, and self-directedness. Higher self-acceptance scores were associated with remission, while female patients exhibited significantly lower AcroQoL-Physical scores than male patients. IGF-1 levels positively correlated with novelty seeking. Qol was negatively correlated with harm avoidance, anxiety, and depression, whereas both anxiety and depression were positively associated with harm avoidance.

Conclusions: Acromegaly is associated with distinct personality patterns that may influence coping, well-being, and treatment experiences. These findings underscore the potential value of integrating psychosocial assessment and personalized support into the management of acromegaly, and highlight the need for further studies to clarify underlying neurobiological and cultural influences.

目的:本研究评估肢端肥大症患者的气质、性格维度、焦虑、抑郁和生活质量(qol),并研究其与疾病活动性、持续时间、治疗方式和肿瘤特征等临床变量的关系。方法:采用横断面研究方法,选取77例肢端肥大症患者和99例与患者年龄、性别无差异的健康对照,填写气质与性格量表(TCI-R)、医院焦虑抑郁量表(HADS)和肢端肥大症生活质量问卷(AcroQoL)。根据缓解状态、治疗类型和组织病理学结果对患者进行亚组。进行组间比较和相关性分析。结果:与对照组相比,肢端肥大症患者表现出较高的冲动性,但较低的情感温暖、持久性和自我指向性。较高的自我接受得分与缓解相关,而女性患者的AcroQoL-Physical得分明显低于男性患者。IGF-1水平与新奇追求呈正相关。生活质量与伤害回避、焦虑和抑郁呈负相关,而焦虑和抑郁与伤害回避均呈正相关。结论:肢端肥大症与可能影响应对、幸福感和治疗经历的独特人格模式相关。这些发现强调了将社会心理评估和个性化支持整合到肢端肥大症管理中的潜在价值,并强调了进一步研究以阐明潜在的神经生物学和文化影响的必要性。
{"title":"Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates.","authors":"Banu Betul Kocaman, Yusuf Cicek, Serdar Sahin, Ahmet Burhan Dogan, Serhat Uysal, Ilkin Muradov, Lala Soltanova, Sabriye Sibel Taze, Nazife Gamze Usta Saglam, Emre Durcan, Senol Turan, Pinar Kadioglu","doi":"10.1007/s11102-025-01622-0","DOIUrl":"10.1007/s11102-025-01622-0","url":null,"abstract":"<p><strong>Objective: </strong>This study evaluated temperament, character dimensions, anxiety, depression, and quality of life (qol) in patients with acromegaly, and examined their associations with clinical variables including disease activity, duration, treatment modality, and tumor characteristics.</p><p><strong>Methods: </strong>In a cross-sectional study, 77 patients with acromegaly and 99 healthy controls with no difference in age and sex compared to patients completed the Temperament and Character Inventory-Revised (TCI-R), Hospital Anxiety and Depression Scale (HADS), and Acromegaly Quality of Life Questionnaire (AcroQoL). Patients were subgrouped by remission status, treatment type, and histopathological findings. Between-group comparisons and correlation analyses were performed.</p><p><strong>Results: </strong>Compared with controls, patients with acromegaly exhibited higher impulsiveness but lower levels of emotional warmth, persistence, and self-directedness. Higher self-acceptance scores were associated with remission, while female patients exhibited significantly lower AcroQoL-Physical scores than male patients. IGF-1 levels positively correlated with novelty seeking. Qol was negatively correlated with harm avoidance, anxiety, and depression, whereas both anxiety and depression were positively associated with harm avoidance.</p><p><strong>Conclusions: </strong>Acromegaly is associated with distinct personality patterns that may influence coping, well-being, and treatment experiences. These findings underscore the potential value of integrating psychosocial assessment and personalized support into the management of acromegaly, and highlight the need for further studies to clarify underlying neurobiological and cultural influences.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"24"},"PeriodicalIF":3.4,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and molecular genetic analysis of children with severe short stature due to isolated growth hormone deficiency: insights from a South Indian cohort and predictors of growth response. 孤立性生长激素缺乏症导致的严重矮小儿童的临床和分子遗传学分析:来自南印度队列的见解和生长反应的预测因素。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-22 DOI: 10.1007/s11102-025-01625-x
Shanmugam Dhivya, Subbiah Sridhar, M Kathirvel, Palaniappan Sreenivasan, Nandini Kuppusamy, Rahila Chellapillai, Jayachandran SenthilKumar

Purpose: Isolated growth hormone deficiency (IGHD) is one of the treatable causes of short stature. We aimed to describe the clinical, biochemical, and molecular characteristics of IGHD and identify clinical predictors of mutation positivity and first-year height response to recombinant human growth hormone (rhGH).

Methods: Sixty-three children with IGHD who were on a minimum of one year of rhGH therapy were included. Detailed auxology, growth hormone provocative testing, and pituitary MRI were performed. Genetic variants were identified by whole-exome sequencing and correlated with auxological and biochemical parameters. The first-year height response was assessed as ΔHeight SDS, and predictors of response were analysed using regression models.

Results: The mean age at presentation was 8.9 ± 2.9 years; 57% were born to consanguineous parents. Severe auxological impairment was observed, with a mean height SDS of - 4.29 ± 1.09, and a mean genetic height deficit of - 2.42 ± 1.12 SDS. Genetic variants were identified in 49% of the cohort, predominantly in GHRHR (39.7%), with the p.Glu72Ter being the most frequent, while GH1 variants were less prevalent (4.8%). Genetic variant-positive children presented at a younger age, with more severe growth failure, and a better response to rhGH therapy. Regression analysis identified genetic variant-positive status as an independent predictor of favourable first-year growth response (ΔHeight-SDS:1.24 ± 0.50).

Conclusion: The South Indian IGHD cohort exhibits a distinct genetic profile, with GHRHR p.Glu72Ter being the most frequent variant, consistent with a founder effect. Severe short stature, low peak stimulated growth hormone levels, and superior first-year growth response indirectly predicted mutation positivity.

目的:孤立性生长激素缺乏症(IGHD)是可治疗的矮小症之一。我们旨在描述IGHD的临床、生化和分子特征,并确定突变阳性和对重组人生长激素(rhGH)第一年身高反应的临床预测因素。方法:63名接受了至少一年的rhGH治疗的IGHD儿童被纳入研究。进行了详细的生长学、生长激素刺激测试和垂体MRI。遗传变异通过全外显子组测序鉴定,并与生理和生化参数相关。采用ΔHeight SDS评估第一年身高反应,并采用回归模型分析预测因素。结果:患者平均发病年龄8.9±2.9岁;57%是近亲出生的。严重的生理缺陷,平均身高SDS为- 4.29±1.09,平均遗传身高缺陷为- 2.42±1.12 SDS。在49%的队列中发现了遗传变异,主要是GHRHR(39.7%),其中p.g ul72ter最常见,而GH1变异不太普遍(4.8%)。遗传变异阳性的儿童出现年龄更小,有更严重的生长衰竭,对rhGH治疗有更好的反应。回归分析发现遗传变异阳性状态是第一年良好生长反应的独立预测因子(ΔHeight-SDS:1.24±0.50)。结论:南印度IGHD队列显示出独特的遗传谱,GHRHR p.g u72ter是最常见的变异,与创始人效应一致。严重的身材矮小,低峰值刺激生长激素水平,以及优越的第一年生长反应间接预测突变阳性。
{"title":"Clinical and molecular genetic analysis of children with severe short stature due to isolated growth hormone deficiency: insights from a South Indian cohort and predictors of growth response.","authors":"Shanmugam Dhivya, Subbiah Sridhar, M Kathirvel, Palaniappan Sreenivasan, Nandini Kuppusamy, Rahila Chellapillai, Jayachandran SenthilKumar","doi":"10.1007/s11102-025-01625-x","DOIUrl":"10.1007/s11102-025-01625-x","url":null,"abstract":"<p><strong>Purpose: </strong>Isolated growth hormone deficiency (IGHD) is one of the treatable causes of short stature. We aimed to describe the clinical, biochemical, and molecular characteristics of IGHD and identify clinical predictors of mutation positivity and first-year height response to recombinant human growth hormone (rhGH).</p><p><strong>Methods: </strong>Sixty-three children with IGHD who were on a minimum of one year of rhGH therapy were included. Detailed auxology, growth hormone provocative testing, and pituitary MRI were performed. Genetic variants were identified by whole-exome sequencing and correlated with auxological and biochemical parameters. The first-year height response was assessed as ΔHeight SDS, and predictors of response were analysed using regression models.</p><p><strong>Results: </strong>The mean age at presentation was 8.9 ± 2.9 years; 57% were born to consanguineous parents. Severe auxological impairment was observed, with a mean height SDS of - 4.29 ± 1.09, and a mean genetic height deficit of - 2.42 ± 1.12 SDS. Genetic variants were identified in 49% of the cohort, predominantly in GHRHR (39.7%), with the p.Glu72Ter being the most frequent, while GH1 variants were less prevalent (4.8%). Genetic variant-positive children presented at a younger age, with more severe growth failure, and a better response to rhGH therapy. Regression analysis identified genetic variant-positive status as an independent predictor of favourable first-year growth response (ΔHeight-SDS:1.24 ± 0.50).</p><p><strong>Conclusion: </strong>The South Indian IGHD cohort exhibits a distinct genetic profile, with GHRHR p.Glu72Ter being the most frequent variant, consistent with a founder effect. Severe short stature, low peak stimulated growth hormone levels, and superior first-year growth response indirectly predicted mutation positivity.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"23"},"PeriodicalIF":3.4,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two-stage surgery for cystic craniopharyngiomas: a purely endoscopic strategy and outcomes. 两阶段手术治疗囊性颅咽管瘤:纯内窥镜策略和结果。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-21 DOI: 10.1007/s11102-025-01618-w
Yoshiki Sato, Kazuhito Takeuchi, Yuichi Nagata, Tomoki Matsuyama, Toshiaki Hirose, Eriko Okumura, Kenichiro Iwami, Ryuta Saito

Purpose: This study aimed to evaluate the effectiveness and safety of two-stage endoscopic surgery for the complete resection of cystic craniopharyngiomas.

Methods: We retrospectively evaluated 11 patients who underwent two-stage endoscopic surgery between March 2020 and July 2025. The lesions showed suprasellar and lateral extension toward the optic chiasm or the foramen of Monro, resulting in visual impairment or obstructive hydrocephalus. Cyst fenestration (CF) was initially performed using a transventricular approach with a flexible endoscope. One to two months later, endoscopic transsphenoidal surgery (eTSS) was performed to achieve complete resection. Tumor size (vertical diameter, horizontal diameter, and volume) was measured at three time points: pre-CF, post-CF (≤ 4 days), and pre-eTSS. Extent of resection, recurrence, and pituitary and hypothalamic function were assessed post-eTSS.

Results: Complete resection was achieved in 10 of 11 patients, with no recurrence during a median follow-up of 22.8 months (range, 3.6-65.3). At a median interval of 54 days (range, 27-86) between CF and eTSS, the mean linear reduction was 45.3% superiorly and 39.3% laterally; mean tumor volume decreased by 68.0%. In some cases, areas typically difficult to access via eTSS alone decreased in size. All preoperative symptoms, except for hypopituitarism and diabetes insipidus, improved immediately after CF. No hypothalamic dysfunction was observed.

Conclusion: Two-stage endoscopic surgery for cystic craniopharyngiomas is effective and safe, enabling complete resection with low recurrence during short- to mid-term follow-up.

目的:本研究旨在评价两期内镜手术完全切除囊性颅咽管瘤的有效性和安全性。方法:我们回顾性评估了11例在2020年3月至2025年7月期间接受了两期内窥镜手术的患者。病变表现为鞍上及外侧向视交叉或Monro孔延伸,导致视力障碍或梗阻性脑积水。囊肿开窗术(CF)最初采用柔性内窥镜经脑室入路进行。1 ~ 2个月后,行内镜下经蝶窦手术(eTSS)实现全切除。在cf前、cf后(≤4天)和etss前三个时间点测量肿瘤大小(垂直直径、水平直径和体积)。etss后评估切除程度、复发、垂体和下丘脑功能。结果:11例患者中有10例完全切除,中位随访22.8个月(范围3.6-65.3)无复发。在CF和eTSS之间的中位间隔54天(范围,27-86),平均线性下降为45.3%,横向下降为39.3%;平均肿瘤体积缩小68.0%。在某些情况下,通常仅通过eTSS难以进入的区域缩小了。除垂体功能低下和尿崩症外,CF后所有术前症状均立即改善。未观察到下丘脑功能障碍。结论:两期内镜手术治疗囊性颅咽管瘤是一种安全有效的手术方法,在中短期随访中能完全切除,复发率低。
{"title":"Two-stage surgery for cystic craniopharyngiomas: a purely endoscopic strategy and outcomes.","authors":"Yoshiki Sato, Kazuhito Takeuchi, Yuichi Nagata, Tomoki Matsuyama, Toshiaki Hirose, Eriko Okumura, Kenichiro Iwami, Ryuta Saito","doi":"10.1007/s11102-025-01618-w","DOIUrl":"10.1007/s11102-025-01618-w","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate the effectiveness and safety of two-stage endoscopic surgery for the complete resection of cystic craniopharyngiomas.</p><p><strong>Methods: </strong>We retrospectively evaluated 11 patients who underwent two-stage endoscopic surgery between March 2020 and July 2025. The lesions showed suprasellar and lateral extension toward the optic chiasm or the foramen of Monro, resulting in visual impairment or obstructive hydrocephalus. Cyst fenestration (CF) was initially performed using a transventricular approach with a flexible endoscope. One to two months later, endoscopic transsphenoidal surgery (eTSS) was performed to achieve complete resection. Tumor size (vertical diameter, horizontal diameter, and volume) was measured at three time points: pre-CF, post-CF (≤ 4 days), and pre-eTSS. Extent of resection, recurrence, and pituitary and hypothalamic function were assessed post-eTSS.</p><p><strong>Results: </strong>Complete resection was achieved in 10 of 11 patients, with no recurrence during a median follow-up of 22.8 months (range, 3.6-65.3). At a median interval of 54 days (range, 27-86) between CF and eTSS, the mean linear reduction was 45.3% superiorly and 39.3% laterally; mean tumor volume decreased by 68.0%. In some cases, areas typically difficult to access via eTSS alone decreased in size. All preoperative symptoms, except for hypopituitarism and diabetes insipidus, improved immediately after CF. No hypothalamic dysfunction was observed.</p><p><strong>Conclusion: </strong>Two-stage endoscopic surgery for cystic craniopharyngiomas is effective and safe, enabling complete resection with low recurrence during short- to mid-term follow-up.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"21"},"PeriodicalIF":3.4,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's reply to the Letter to the Editor by M Vijayasimha "Standardizing blood pressure phenotyping in acromegaly: a practical companion to Araujo-Castro et al." 作者对M Vijayasimha给编辑的信的回复“规范肢端肥大症的血压表型:Araujo-Castro等人的实用伴侣”。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-21 DOI: 10.1007/s11102-025-01623-z
Marta Araujo-Castro, Pedro Marques, Betina Biagetti
{"title":"Author's reply to the Letter to the Editor by M Vijayasimha \"Standardizing blood pressure phenotyping in acromegaly: a practical companion to Araujo-Castro et al.\"","authors":"Marta Araujo-Castro, Pedro Marques, Betina Biagetti","doi":"10.1007/s11102-025-01623-z","DOIUrl":"10.1007/s11102-025-01623-z","url":null,"abstract":"","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"22"},"PeriodicalIF":3.4,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controlling cortisol excess and comorbidities in Cushing's syndrome with osilodrostat. 奥西洛他汀控制库欣综合征皮质醇过量及合并症。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-21 DOI: 10.1007/s11102-025-01605-1
Maria Fleseriu, John Newell-Price, Mônica R Gadelha, Beverly M K Biller
{"title":"Controlling cortisol excess and comorbidities in Cushing's syndrome with osilodrostat.","authors":"Maria Fleseriu, John Newell-Price, Mônica R Gadelha, Beverly M K Biller","doi":"10.1007/s11102-025-01605-1","DOIUrl":"10.1007/s11102-025-01605-1","url":null,"abstract":"","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"20"},"PeriodicalIF":3.4,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12719344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database. 高龄垂体腺瘤患者的手术治疗:监测、流行病学和最终结果数据库的多变量评估。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-20 DOI: 10.1007/s11102-025-01612-2
Jacob Gould, Arjit Singh, Saarang Patel, Noah Yaffe, Guan Li, Lou Blanpain, Julian L Gendreau

Background: The management of pituitary adenomas in very elderly patients (age ≥ 85 years) remains challenging due to age-related frailty and variability in treatment tolerance. This study aimed to identify clinical and sociodemographic factors associated with survival in patients age ≥ 85 years with pituitary adenoma and assess the plausibility of surgical resection.

Methods: Patients aged 85 and up (very elderly cohort) were queried from the SEER database. Additionally, patients from the age range of 75-84 (elderly cohort) were queried for comparisons. Demographic variables, adenoma size, and treatment variables were assessed, and differences were identified using a Chi-squared tests for independence and two-sample t-tests. Differences in survival were assessed using multivariable Cox proportional hazards models stratified by age cohort. Kaplan-Meier plots were generated to assess survival differences among treatment groups in the very elderly cohort.

Results: Across all cohorts, subtotal resection and female sex were independently associated with improved survival and age was associated with worse survival. For the very elderly cohort, adenoma size (HR = 1.004; p = 0.005) was associated with worse overall survival, while female sex (HR = 0.656; p < 0.001) and subtotal resection (HR = 0.557; p = 0.005) were associated with increased overall survival. Black race was associated with worse survival in the 75-84 elderly cohort only (HR = 1.479; p < 0.001).

Conclusion: In patients ≥ 85 years of age with pituitary adenoma, surgical resection appears to provide an overall benefit to survival and should be considered among other factors.

背景:高龄患者(≥85岁)的垂体腺瘤的治疗仍然具有挑战性,因为年龄相关的虚弱和治疗耐受性的变化。本研究旨在确定与年龄≥85岁垂体腺瘤患者生存相关的临床和社会人口学因素,并评估手术切除的可行性。方法:从SEER数据库中查询年龄在85岁及以上的患者(高龄队列)。此外,还查询了年龄在75-84岁(老年队列)的患者进行比较。对人口统计学变量、腺瘤大小和治疗变量进行评估,并使用卡方检验和两样本t检验确定差异。生存率差异采用多变量Cox比例风险模型按年龄队列分层进行评估。生成Kaplan-Meier图来评估老年队列中治疗组之间的生存差异。结果:在所有队列中,次全切除术和女性与生存率的提高独立相关,年龄与生存率的降低相关。在高龄队列中,腺瘤大小(HR = 1.004; p = 0.005)与较差的总生存率相关,而女性(HR = 0.656; p)与较差的总生存率相关。结论:对于年龄≥85岁的垂体腺瘤患者,手术切除似乎对总体生存率有好处,应在其他因素中加以考虑。
{"title":"Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database.","authors":"Jacob Gould, Arjit Singh, Saarang Patel, Noah Yaffe, Guan Li, Lou Blanpain, Julian L Gendreau","doi":"10.1007/s11102-025-01612-2","DOIUrl":"10.1007/s11102-025-01612-2","url":null,"abstract":"<p><strong>Background: </strong>The management of pituitary adenomas in very elderly patients (age ≥ 85 years) remains challenging due to age-related frailty and variability in treatment tolerance. This study aimed to identify clinical and sociodemographic factors associated with survival in patients age ≥ 85 years with pituitary adenoma and assess the plausibility of surgical resection.</p><p><strong>Methods: </strong>Patients aged 85 and up (very elderly cohort) were queried from the SEER database. Additionally, patients from the age range of 75-84 (elderly cohort) were queried for comparisons. Demographic variables, adenoma size, and treatment variables were assessed, and differences were identified using a Chi-squared tests for independence and two-sample t-tests. Differences in survival were assessed using multivariable Cox proportional hazards models stratified by age cohort. Kaplan-Meier plots were generated to assess survival differences among treatment groups in the very elderly cohort.</p><p><strong>Results: </strong>Across all cohorts, subtotal resection and female sex were independently associated with improved survival and age was associated with worse survival. For the very elderly cohort, adenoma size (HR = 1.004; p = 0.005) was associated with worse overall survival, while female sex (HR = 0.656; p < 0.001) and subtotal resection (HR = 0.557; p = 0.005) were associated with increased overall survival. Black race was associated with worse survival in the 75-84 elderly cohort only (HR = 1.479; p < 0.001).</p><p><strong>Conclusion: </strong>In patients ≥ 85 years of age with pituitary adenoma, surgical resection appears to provide an overall benefit to survival and should be considered among other factors.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"18"},"PeriodicalIF":3.4,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic performance of desmopressin stimulation test in pediatric cushing's disease. 去氨加压素刺激试验对儿童库欣病的诊断价值。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-20 DOI: 10.1007/s11102-025-01610-4
Yetunde B Omotosho, Richard Chang, Michael Kassin, Erna Groat, Alan Quillian, Ruth Parker, Christina Tatsi
{"title":"Diagnostic performance of desmopressin stimulation test in pediatric cushing's disease.","authors":"Yetunde B Omotosho, Richard Chang, Michael Kassin, Erna Groat, Alan Quillian, Ruth Parker, Christina Tatsi","doi":"10.1007/s11102-025-01610-4","DOIUrl":"10.1007/s11102-025-01610-4","url":null,"abstract":"","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"19"},"PeriodicalIF":3.4,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718224/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery. 微创术中超声在垂体内镜手术中的应用效果。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-16 DOI: 10.1007/s11102-025-01587-0
Min Ho Lee, Yeon Hee Im, Ji-Hyeon Shin, Tae-Kyu Lee

Objective: This study aims to evaluate the clinical utility of minimally invasive intraoperative ultrasound as a real-time imaging adjunct during endoscopic endonasal pituitary adenoma surgery. The goal is to determine its effectiveness in tumor localization, identification of critical structures, and detection of residual tumor tissue.

Methods: A retrospective analysis was conducted on 22 patients who underwent endoscopic endonasal pituitary surgery with intraoperative ultrasound at our institution from August 2024 to June 2025. The ultrasound probe was used before dural opening to identify the tumor, normal gland, and adjacent structures, including the internal carotid artery (ICA). After tumor resection, ultrasound was employed to assess residual tumor. Clinical and surgical outcomes, including extent of resection and perioperative complications, were reviewed.

Results: Intraoperative ultrasound enabled clear visualization of the tumor-normal gland interface in both solid and cystic macroadenomas, facilitating safe and precise resection. The technique aided in identification of the ICA during cavernous sinus invasion, reducing vascular injury risk. In cases where tumors were not visible on preoperative magnetic resonance imaging (MRI), intraoperative ultrasound successfully detected the lesions, allowing targeted resection. Gross total resection (GTR) was achieved in 86.4% of cases. The median follow-up was 8 months (range, 3-13 months). There were no new postoperative hormonal deficits. Transient diabetes insipidus occurred in three cases, and all resolved within three months.

Conclusion: Intraoperative ultrasound provides real-time, high-resolution imaging that enhances the precision and safety of endoscopic pituitary surgery. The technique is particularly valuable for tumor localization, identification of critical neurovascular structures, and detection of residual tumor tissue. Further studies are warranted to validate a broader applicability and refine its role in differentiating tumor from normal gland tissue.

目的:本研究旨在评估微创术中超声作为鼻内垂体腺瘤内镜手术中实时成像辅助手段的临床应用价值。目的是确定其在肿瘤定位、关键结构识别和残留肿瘤组织检测中的有效性。方法:回顾性分析我院2024年8月至2025年6月22例经鼻内窥镜下垂体手术伴术中超声的患者。在硬脑膜打开前使用超声探头识别肿瘤、正常腺体和邻近结构,包括颈内动脉(ICA)。肿瘤切除后,超声检查残余肿瘤。回顾了临床和手术结果,包括切除程度和围手术期并发症。结果:术中超声能清晰显示实性和囊性大腺瘤的瘤-正常腺体界面,便于安全、精确的切除。该技术有助于识别海绵窦侵袭时的ICA,降低血管损伤的风险。在术前磁共振成像(MRI)未见肿瘤的病例中,术中超声成功地检测到病变,允许靶向切除。总切除(GTR)率达86.4%。中位随访为8个月(范围3-13个月)。术后无新的激素缺乏。短暂性尿崩症3例,均在3个月内痊愈。结论:术中超声可提供实时、高分辨率成像,提高垂体内镜手术的精度和安全性。该技术对肿瘤定位、关键神经血管结构的识别和残留肿瘤组织的检测尤其有价值。需要进一步的研究来验证其更广泛的适用性,并完善其在区分肿瘤与正常腺体组织中的作用。
{"title":"The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery.","authors":"Min Ho Lee, Yeon Hee Im, Ji-Hyeon Shin, Tae-Kyu Lee","doi":"10.1007/s11102-025-01587-0","DOIUrl":"10.1007/s11102-025-01587-0","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to evaluate the clinical utility of minimally invasive intraoperative ultrasound as a real-time imaging adjunct during endoscopic endonasal pituitary adenoma surgery. The goal is to determine its effectiveness in tumor localization, identification of critical structures, and detection of residual tumor tissue.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 22 patients who underwent endoscopic endonasal pituitary surgery with intraoperative ultrasound at our institution from August 2024 to June 2025. The ultrasound probe was used before dural opening to identify the tumor, normal gland, and adjacent structures, including the internal carotid artery (ICA). After tumor resection, ultrasound was employed to assess residual tumor. Clinical and surgical outcomes, including extent of resection and perioperative complications, were reviewed.</p><p><strong>Results: </strong>Intraoperative ultrasound enabled clear visualization of the tumor-normal gland interface in both solid and cystic macroadenomas, facilitating safe and precise resection. The technique aided in identification of the ICA during cavernous sinus invasion, reducing vascular injury risk. In cases where tumors were not visible on preoperative magnetic resonance imaging (MRI), intraoperative ultrasound successfully detected the lesions, allowing targeted resection. Gross total resection (GTR) was achieved in 86.4% of cases. The median follow-up was 8 months (range, 3-13 months). There were no new postoperative hormonal deficits. Transient diabetes insipidus occurred in three cases, and all resolved within three months.</p><p><strong>Conclusion: </strong>Intraoperative ultrasound provides real-time, high-resolution imaging that enhances the precision and safety of endoscopic pituitary surgery. The technique is particularly valuable for tumor localization, identification of critical neurovascular structures, and detection of residual tumor tissue. Further studies are warranted to validate a broader applicability and refine its role in differentiating tumor from normal gland tissue.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"17"},"PeriodicalIF":3.4,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145763516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standardizing blood pressure phenotyping in acromegaly: A practical companion to Araujo-Castro et al. 规范肢端肥大症的血压表型:Araujo-Castro等人的实用伴侣。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-12-10 DOI: 10.1007/s11102-025-01620-2
M Vijayasimha

Hypertension affects nearly half of patients with acromegaly, yet current studies inconsistently report blood pressure phenotypes due to variability in the use of office, home, and ambulatory monitoring. This companion article proposes a standardized, risk-stratified approach using ambulatory and home blood pressure monitoring to classify sustained, masked, and nocturnal hypertension and to guide antihypertensive de-escalation in relation to biochemical control. The framework incorporates key timepoints-diagnosis, early post-therapy reassessment, and long-term follow-up-while emphasizing modality-specific diagnostic thresholds, dipping patterns, and cardiovascular risk profiles. Structured follow-up using periodic ambulatory blood pressure monitoring and validated home monitoring enables more precise phenotyping, optimizes treatment decisions, and improves comparability across future acromegaly cohorts.

高血压影响近一半的肢端肥大症患者,但由于办公室、家庭和门诊监测的使用差异,目前的研究不一致地报告了血压表型。这篇文章提出了一种标准化的、风险分层的方法,使用动态和家庭血压监测对持续、隐匿和夜间高血压进行分类,并指导与生化控制相关的降压。该框架纳入了关键时间点——诊断、早期治疗后再评估和长期随访,同时强调了特定模式的诊断阈值、倾斜模式和心血管风险概况。采用定期动态血压监测和经过验证的家庭监测进行结构化随访,可以更精确地进行表型分析,优化治疗决策,并提高未来肢端肥大症队列的可比性。
{"title":"Standardizing blood pressure phenotyping in acromegaly: A practical companion to Araujo-Castro et al.","authors":"M Vijayasimha","doi":"10.1007/s11102-025-01620-2","DOIUrl":"10.1007/s11102-025-01620-2","url":null,"abstract":"<p><p>Hypertension affects nearly half of patients with acromegaly, yet current studies inconsistently report blood pressure phenotypes due to variability in the use of office, home, and ambulatory monitoring. This companion article proposes a standardized, risk-stratified approach using ambulatory and home blood pressure monitoring to classify sustained, masked, and nocturnal hypertension and to guide antihypertensive de-escalation in relation to biochemical control. The framework incorporates key timepoints-diagnosis, early post-therapy reassessment, and long-term follow-up-while emphasizing modality-specific diagnostic thresholds, dipping patterns, and cardiovascular risk profiles. Structured follow-up using periodic ambulatory blood pressure monitoring and validated home monitoring enables more precise phenotyping, optimizes treatment decisions, and improves comparability across future acromegaly cohorts.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 1","pages":"16"},"PeriodicalIF":3.4,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145715458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pituitary
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1